Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 399-409
Closed Access | Times Cited: 6
Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project
Andrea Spini, Luca L’Abbate, Ylenia Ingrasciotta, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 395-407
Open Access | Times Cited: 5
Inflammatory Bowel Diseases in the Elderly: A Focus on Disease Characteristics and Biological Therapy Patterns
Renata Talar‐Wojnarowska, M Caban, Marta Jastrzębska, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2767-2767
Open Access | Times Cited: 4
Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world
Irma Convertino, Luciane Cruz Lopes, Nicole Pratt, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis
Shafie Fazel, Massimo Carollo, Lisanne Tap, et al.
Drugs & Aging (2025)
Open Access
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network
Federica Soardo, Andrea Spini, Giorgia Pellegrini, et al.
BioDrugs (2025)
Open Access
Bowel urgency in ulcerative colitis assessed from patients’ reports: Results of a telemonitoring programme
E. Carboni, F Stalla, Marco Mendolaro, et al.
Digestive and Liver Disease (2025)
Open Access
Adverse Event Profiles of Adalimumab in Children: A Disproportionality Analysis
Wenting Zhang, Ziqi Xu, Yamin Shu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1028-1028
Open Access | Times Cited: 3
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis
Mario Gaio, Maria Giovanna Vastarella, Maria Giuseppa Sullo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 904-904
Open Access | Times Cited: 2
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study
Bernhard Korge, O. Vanhooteghem, Charles Lynde, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2077-2092
Open Access | Times Cited: 1
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction
Filippo Vernia, Sabrina Monaco, Giovanni Latella
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 3993-3993
Open Access | Times Cited: 1
Comments on “Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project” [Letter]
Fitri Rokhmalia, Dwi Krihariyani, Sari Luthfiyah, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 431-432
Open Access
Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey
Tuğba Ocak, Burcu Yağız, Birol Ocak, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6216-6216
Open Access
Medication Burden Before and After Prescription of Biologics in Patients with Inflammatory Bowel Disease
Anthony F. Milano, Sarah Krieg, Karel Kostev
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6408-6408
Open Access
How Much Frequently are Biological Drugs Used in Older Patients with Immune-Mediated Inflammatory Diseases? Results from the Large-Scale Italian Valore Distributed Database Network
Federica Soardo, Andrea Spini, Giorgia Pellegrini, et al.
(2024)
Closed Access
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
Sara Lopes, Michela Servadio, Andrea Spini, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-13
Open Access
Page 1

Scroll to top